Simplex Trading’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Buy
62,400
+52,600
+537% +$2.06M ﹤0.01% 1779
2025
Q4
$454K Sell
9,800
-75,000
-88% -$4.11M ﹤0.01% 3395
2025
Q3
$5.73M Buy
84,800
+12,600
+17% +$934K ﹤0.01% 1342
2025
Q2
$6.05M Sell
72,200
-110,100
-60% -$8.24M ﹤0.01% 1206
2025
Q1
$13M Buy
182,300
+120,100
+193% +$5.85M 0.01% 724
2024
Q4
$2.79M Buy
62,200
+36,500
+142% +$1.89M ﹤0.01% 1915
2024
Q3
$1.3M Buy
25,700
+15,500
+152% +$742K ﹤0.01% 2676
2024
Q2
$416K Buy
10,200
+3,800
+59% +$161K ﹤0.01% 3846
2024
Q1
$273K Buy
6,400
+5,300
+482% +$240K ﹤0.01% 4507
2023
Q4
$44K Buy
+1,100
New +$31.3K ﹤0.01% 6207
2022
Q1
Sell
-1,427
Closed -$8K 11311
2021
Q4
$8K Sell
1,427
-1,846
-56% -$19.4K ﹤0.01% 9222
2021
Q3
$54K Buy
3,273
+6
+0.2% +$84 ﹤0.01% 7430
2021
Q2
$55K Buy
3,267
+3,260
+46,571% +$55.1K ﹤0.01% 7538
2021
Q1
$12K Buy
7
+6
+600% +$193 ﹤0.01% 7807
2020
Q4
$2K Sell
1
-6
-86% -$173 ﹤0.01% 8009
2020
Q3
$24K Sell
7
-9
-56% -$263 ﹤0.01% 6256
2020
Q2
$51K Buy
+16
New +$693 ﹤0.01% 5480

Other funds holding SLNO

Simplex Trading's SLNO Position: Q1 2026 in Review

Simplex Trading reduced its Soleno Therapeutics (SLNO) stake by 63% in Q1 2026, selling an estimated $1.21M and leaving 18,166 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Simplex Trading first reported a position in SLNO in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.27M in Q4 2025. 225 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Simplex Trading held 18,166 shares of Soleno Therapeutics worth $608K as of Q1 2026.
  • Simplex Trading sold 30,942 Soleno Therapeutics shares in Q1 2026, an estimated $1.21M.
  • Soleno Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3044 holding.
  • Simplex Trading first reported a position in Soleno Therapeutics in Q4 2020 and has held it in 10 quarters since.
  • Simplex Trading's Soleno Therapeutics position peaked at $2.27M in Q4 2025.
  • 225 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.